Clinical Trial Update: CART-meso Long-term Follow-up

View source ↗

Summary

Clinical trial update reporting long-term follow-up data for subjects treated with lentiviral-based CART-meso therapy in mesothelioma, providing extended safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• CART-meso (mesothelin-targeted CAR T-cell therapy)

Snippet

Sponsor: University of Pennsylvania | Conditions: Subjects Who Have Received Lentiviral-based CART-meso Therapy | Status: COMPLETED